Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
555.40    0.00 (0.00%)
Bid:
557.00
Ask:
557.20
Spread: 0.20 (0.036%)
Market Cap: £3.55b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Form 8.3 - Entain Plc

19 Oct 2021 11:50

Ninety One UK Ltd - Form 8.3 - Entain Plc

Ninety One UK Ltd - Form 8.3 - Entain Plc

PR Newswire

London, October 19

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Ninety One UK Ltd
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Ninety One SA (Pty) Ltd
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeEntain plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:No
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure18 October 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Common Stock EUR 0.01
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:6,649,9751.13
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:6,649,9751.13

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
EUR0.01Sale14,51821.2400

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:19 October 2021
Contact name:Ian Gartshore
Telephone number*:020 3938 1825

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
13th Nov 20257:00 amRNSPricing of €500 million Senior Secured Notes
10th Nov 20258:00 amRNSProposed Refinancing Transaction
6th Nov 20253:10 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSQ3 Trading Update
14th Oct 202512:00 pmRNSBetMGM Q3 2025 Update and Raised FY25 Guidance
14th Oct 20258:59 amRNSTR1: Notification of Major Holdings
1st Oct 20257:01 amRNSBlock Listing Six Monthly Return
1st Oct 20257:00 amRNSTotal Voting Rights
5th Sep 20252:44 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amRNSTotal Voting Rights
12th Aug 20257:01 amRNSInterim Results
12th Aug 20257:00 amRNSAppointment of Non-Executive Chair
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSSuccessful repricing and extension of Term Loans
29th Jul 20257:00 amRNSBETMGM 2Q/1H 2025 UPDATE & FY25 GUIDANCE INCREASE
3rd Jul 20252:00 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20259:00 amRNS-RNew Zealand Government Establishes Legislative Net
16th Jun 20257:00 amRNSBetMGM - Upgraded FY 2025 Guidance
4th Jun 20259:48 amRNSDirector/PDMR Shareholding
2nd Jun 202510:26 amRNSTotal Voting Rights
15th May 20257:00 amRNSBoard Appointments
6th May 202512:34 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 20257:01 amRNSQ1 Trading Update
29th Apr 20257:00 amRNSAppointment of Chief Executive Officer
28th Apr 202512:00 pmRNSBetMGM Q1 2025 Update
23rd Apr 202511:59 amRNSResult of AGM
4th Apr 202510:20 amRNSTR1: Notification of Major Holdings
3rd Apr 20259:35 amRNSDirector/PDMR Shareholding
1st Apr 20257:01 amRNSBlock Listing Six Monthly Return
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:33 pmRNSAnnual Report, AGM and Directorate Change
19th Mar 202510:39 amRNSDirector/PDMR Shareholding
17th Mar 20259:46 amRNSTR1: Notification of Major Holdings
10th Mar 20252:24 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
3rd Mar 20257:00 amRNSTotal Voting Rights
14th Feb 20251:52 pmRNSDirectorate and Board Committee Changes
14th Feb 202510:49 amRNSTR1: Notification of Major Holdings
11th Feb 20257:00 amRNSDirectorate Change
4th Feb 202512:00 pmRNSBETMGM FY 2024 Update
31st Jan 20257:00 amRNSTR1: Notification of Major Holdings
13th Jan 20257:00 amRNSReiteration of FY24 EBITDA guidance
6th Jan 20259:06 amRNSDirector/PDMR Shareholding
3rd Jan 202512:04 pmRNSBlock Listing Six Monthly Return
2nd Jan 20257:50 amRNSTotal Voting Rights
17th Dec 20247:00 amRNSBlock Listing Application
16th Dec 20247:00 amRNSAcknowledgement of AUSTRAC Proceedings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.